5 April 2007
ELLEX ENTERS CHINESE OPHTHALMIC LASER MARKET 
Adelaide, Australia, 4 April 2007 -- Ellex Medical Lasers Limited (ASX:ELX), a global leader in the design and manufacture of ophthalmic laser and ultrasound systems, announced today that it has appointed GT Medical, a division of Guotong Holdings Company Limited, as its exclusive distributor in China. Ellex also announced that they have secured key regulatory approvals for 5 of its 7 core laser products and are pursuing approval of the remaining 2, which are expected to be secured later this calendar year. In addition, Ellex will commence the approvals process for the Innovative Imaging ultrasound device this year.
Mr. Peter Falzon, CEO, stated that Ellex selected GT Medical based on their financial and human resource infrastructure that will support Ellex’s long term strategy in China. “We see a significant opportunity in China and believe we have selected a partner that will position Ellex as a leader in this rapidly expanding market” said Mr Falzon.
GT Medical will launch the Ellex product range at the upcoming 7th International Congress of Ophthalmology & Optometry, Shanghai, China in April which is the largest ophthalmic trade show in China. Professor John Marshall, chairman of the Ellex Medical Advisory Board and Professor of Ophthalmology at St Thomas’s Hospital in London will address the congress as a keynote speaker to introduce SLT photoregeneration therapy for glaucoma using Ellex’s Tango and Solo SLT laser systems. A number of other marketing events and symposia are also planned in the upcoming months to support the launch of Ellex products in China.